AKT1 and hepatocellular carcinoma: This exacerbates AKT signaling, effectively reducing not only Caspase-3-mediated apoptosis but also chemotherapy-induced apoptosis (via doxorubicin/adriamycin and cisplatin) in HCC cells [24].